Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 12 of 12 publications.

Mrus JM, Braun L, Yi MS, Linde-Zwirble WT, Johnston JA. Impact of HIV/AIDS on care and outcomes of severe sepsis. Crit Care. 2005 Nov 1;9(6):R623-30.

Earnshaw SR, Candrilli SD, Fernandes AW, Higashi MK. A cost-effectiveness analysis of antibiotic therapy in macrolide-resistant community-acquired pneumonia. Managed Care Interface. 2005 Oct 1;18(10):36-44.

Smith SR, Brock TP, Howarth SM. Use of personal digital assistants to deliver education about adherence to antiretroviral medications. J Am Pharm Assoc. 2005 Sep;45(5):625-8.

Mauskopf J, Kitahata M, Kauf TL, Richter A, Tolson JM. HIV antiretroviral treatment: early versus later. J Acquir Immune Defic Syndr. 2005 Aug 15;39(5):562-9.

Poulos C, Malik R, Guh S, Utomo N, Nyamete A. Household demand for typhoid fever vaccines in North Jakarta, Indonesia. Poster presented at the Investing in Health, the 5th World Congress of the International Health Economists Association; July 2005. Amsterdam, The Netherlands.

Tafesse E, Claxton A, Granger AL, Sanders J, Apelian D, Atillasoy E, Iloeje U. Estimates of health care costs for lamivudine-refractory chronic hepatitis b (CHB) patients. Poster presented at the 2005 ISPOR 10th Annual International Meeting; May 18, 2005. [abstract] Value Health. 2005 May; 8(3):310.

Richter A, Pladevall M, Manjunath R, Lafata JE, Xi H, Simpkins J, Brar I, Markowitz N, Iloeje U, Irish W. Patient characteristics and costs associated with dyslipidaemia and related conditions in HIV-infected patients: a retrospective cohort study. HIV Med. 2005 Mar 1;6(2):79-90.

Legendre C, Beard SM, Crochard A, Lebranchu Y, Pouteil-Noble C, Richter A, Durand-Zaleski I. The cost-effectiveness of prophylaxis with valaciclovir in the management of cytomegalovirus after renal transplantation. Eur J Health Econ. 2005 Mar 1;6(2):172-82.

Wenzel R, Del Favero A, Kibbler C, Rogers T, Rotstein C, Mauskopf J, Morris S, Schlamm H, Troke P, Marciniak A. Economic evaluation of voriconazole compared with conventional amphotericin B for the primary treatment of aspergillosis in immunocompromised patients. J Antimicrob Chemother. 2005 Feb 22;55(3):352-61.

Iloeje U, Yuan Y, L'italien G, Mauskopf J, Holmberg S, Moorman A, Wood K, Moore R. Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients. HIV Med. 2005 Jan 1;6(1):37-44.

Nemoto T, Iwamoto M, Oh HJ, Witt S, Le K, Chu H. Hiv prevention and health promotion for hard-to-reach and stigmatized population: asian women working at massage parlors in San Francisco. Poster presented at the 133rd Annual Meeting and Exposition of the American Public Health Association; 2005.

Sirkus L, Lukacs S, Branum A. Quickstats: rate of hospitalizations for pertussis among infants aged <6 months – United States, 1994-1998 and 1999-2003. MMWR Surveill Summ. 2005;54:1027.